Result of AGM

GlaxoSmithKline PLC
19 May 2003

Issued - Monday 19 May 2003, London (LSE Announcement)


                        GlaxoSmithKline - Results of AGM

GlaxoSmithKline (GSK) announces that at today's Annual General Meeting all
Resolutions, including those re-electing Board members, were passed by
substantial majorities except for Resolution 2, on the Remuneration Report,
which was not passed.

GSK's Chairman, Sir Christopher Hogg, said: "Although Resolution 2 is advisory,
the Board takes this result very seriously. The major reason for this negative
vote has been the fact that there are elements of our senior level remuneration
package which do not accord with what is regarded as best practice by some
shareholders. That is something that the Board is aware of and it was one of the
reasons that the Remuneration Committee decided to appoint Deloitte & Touche
some months ago to conduct a completely independent review of our approach.

"The review includes all aspects of remuneration, including those to which we
are bound contractually. It will bear firmly in mind the new expanded guidelines
on executive remuneration which the Association of British Insurers issued in
December 2002, as well as the need to ensure that the remuneration we offer our
key executives and scientists is competitive with that provided by other
pharmaceutical companies. The Board clearly registers shareholders' particular
sensitivity to contractual notice periods and payments on termination."

"We look forward to consulting further with leading shareholders in the coming
months on our proposals to balance these objectives."

              GlaxoSmithKline Annual General Meeting Poll Results

The following table shows the votes cast for each Resolution:
                                                                                                 Total Votes Against
        Resolution                                             Total Votes For*

     1. Adoption of Financial Statements                                   3,476,455,197                 172,154,655
     2. Approval of the Remuneration Report                                1,398,142,951               1,439,003,920
     3. Re-election of Sir Christopher Hogg                                3,512,549,248                  77,220,034
     4. Re-election of Dr J-P Garnier                                      2,837,194,148                 609,799,658
     5. Re-election of Sir Roger Hurn                                      3,271,098,730                 279,956,581
     6. Re-election of Mr J D Coombe                                       2,947,121,853                 500,418,118
     7. Re-election of Sir Peter Job                                       3,550,398,820                 118,117,260
     8. Re-election of Mr John McArthur                                    3,459,759,457                 117,805,522
     9. Re-election of Donald McHenry                                      3,401,184,976                  71,839,485
    10. Re-election of Sir Ian Prosser                                     3,692,961,313                  66,211,001
    11. Re-election of Dr Ronaldo Schmitz                                  3,692,827,694                  66,335,781
    12. Re-election of Dr Lucy Shapiro                                     3,632,843,642                  65,009,665
    13. Re-appointment of Auditors                                         3,511,733,511                 159,297,520
    14. Remuneration of Auditors                                           3,582,829,535                  33,184,974
    15. Authorise donations to EU Political                                3,452,000,341                 212,896,986
        Organisations & incur EU Political
        Expenditure
    16. Disapplication of pre-emption rights**                             3,761,514,669                  28,733,107
    17. Authority for the Company to purchase its own                      3,614,549,832                  24,330,655
        shares**

*     Includes discretionary votes

**     Indicates Special Resolutions requiring a 75% majority

S M Bicknell

Company Secretary

19th May 2003



Enquiries:
UK Media enquiries:                                     Martin Sutton            [phone]
                                                        David Mawdsley           [phone]

US Media enquiries:                                     Nancy Pekarek            [phone]
                                                        Mary Anne Rhyne          [phone]
                                                        Patricia Seif            [phone]

European Analyst/Investor enquiries:                    Duncan Learmouth         [phone]
                                                        Anita Kidgell            [phone]
                                                        Philip Thomson           [phone]

US Analyst/ Investor enquiries:                         Frank Murdolo            [phone]
                                                        Tom Curry                [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange